Legal Matters: Research Under Institutional Review Board Approval: A Clinical Means to a Legal End.Published in:Alternative & Complementary Therapies, 2007, v. 13, n. 1, p. 44, doi. 10.1089/act.2006.13108By:Dumoff, AlanPublication type:Article
Questioning the "Right" in State Right to Try Laws: Assessing the Legality and Effectiveness of These Laws.Published in:Ohio State Law Journal, 2016, v. 77, n. 1, p. 159By:MARTIN, CAITLYNPublication type:Article
Policy Watch. FDA user fee renewal addresses drug shortages, new drug development.Published in:Formulary, 2012, v. 47, n. 3, p. 125By:Wechsler, JillPublication type:Article
Focus on 2010: A year of novel pharmacologic agents in review.Published in:Formulary, 2010, v. 45, n. 11, p. 350Publication type:Article
"Right to Try" Legislation and Its Implications for the FDA Drug Approval Process.Published in:Washington University Journal of Law & Policy, 2016, v. 50, p. 171By:Hogan, EmilyPublication type:Article